Exploring Microglia Transplantation as a Potential Therapy for Neurodegenerative Diseases

Recent scientific advancements suggest that immune cells in the brain, specifically microglia, may play a crucial role in combating the progression of neurodegenerative diseases such as Alzheimer’s. Researchers from the Institute of Neuroscience at Xiamen University in China are investigating innovative therapies involving the transplantation of healthy microglia to protect and restore neuronal health.

Currently in the pre-clinical phase, these studies aim to develop methods that effectively replace dysfunctional microglia without the need for harsh preconditioning treatments like radiation or chemotherapy. Traditional approaches, such as bone marrow transplants, face limitations due to their arduous procedures and potential risks, including brain damage. To address these challenges, scientists have devised a novel strategy called tricyclic microglial depletion, which allows for the selective removal of defective microglia and subsequent transplantation of healthy cells.

This method involves cycles of an experimental compound, PLX3397, which inhibits the CSF1R receptor on immune cells, promoting the proliferation of transplanted microglia within the brain. These cells, originating from blood-forming tissues, are essential in fighting infections, clearing debris, and repairing tissues in the central nervous system. The research demonstrates that transplanted microglia can engraft effectively and adopt properties similar to native microglia in mouse models.

Experiments have shown promising results, with these cell transplants slowing neurodegeneration and alleviating symptoms in models of Alzheimer’s and Sandhoff disease. The researchers emphasize the importance of further studies to understand the mechanisms of engraftment and to explore human-induced pluripotent stem cells as a potential source for clinical applications. Ultimately, this innovative microglia replacement approach might become a translatable therapy for various neurological conditions linked to microglial dysfunction, opening new avenues for treating devastating neurodegenerative disorders.